Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
作者信息
Forester D
出版信息
Chest. 1979 Jun;75(6):745. doi: 10.1378/chest.75.6.745a.
PMID:436537
Abstract
摘要
相似文献
1
Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
Chest. 1979 Jun;75(6):745. doi: 10.1378/chest.75.6.745a.
2
Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation.
Ann Intern Med. 1976 Jan;84(1):44-5. doi: 10.7326/0003-4819-84-1-44.
3
Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
Chest. 1978 Dec;74(6):624-8. doi: 10.1378/chest.74.6.624.
4
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Herz. 1983 Jun;8(3):133-43.
5
Treatment of cardiac arrhythmias.
Pediatr Clin North Am. 1964 May;11(2):315-62. doi: 10.1016/s0031-3955(16)31553-x.
6
Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.
Circulation. 1977 Jan;55(1):15-22. doi: 10.1161/01.cir.55.1.15.
7
Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
Am Heart J. 1975 Jun;89(6):804-8. doi: 10.1016/0002-8703(75)90197-0.
8
Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Am J Cardiol. 1978 Dec;42(6):1049-53. doi: 10.1016/0002-9149(78)90694-x.
9
The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
Chest. 1977 May;71(5):597-606. doi: 10.1378/chest.71.5.597.
10
[Contraindications to the use of digitalis in atrial fibrillation in the course of Wolff-Parkinson-White syndrome].
Boll Soc Ital Cardiol. 1974;19(2):181-6.
引用本文的文献
1
Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.
Drugs. 1987 Aug;34(2):151-87. doi: 10.2165/00003495-198734020-00001.
Zotero 插件